# SYSTEM_EVALUATION_FRAMEWORK

---

# DOCUMENT METADATA

Document ID:
DOC-OPS-001

Version:
1.0

Status:
LOCKED

Authority:
OPERATIONS

Owner:
Project Coordinator

Strategist:
ChatGPT

Implementation:
Claude

Depends On:
OUTPUT_VALIDATION_FRAMEWORK.md
DELIVERY_POLICY.md
RESPONSE_GENERATION_ARCHITECTURE.md

Required By:
MONITORING_FRAMEWORK.md
OBSERVABILITY_FRAMEWORK.md
RELEASE_POLICY.md

Last Updated:
2026-08-03

---

# 1. PURPOSE

This document defines the System Evaluation Framework of the Safe Medical AI System.

The framework establishes standardized principles, evaluation dimensions, datasets, metrics, governance, and release criteria for evaluating the complete end-to-end system while remaining independent of implementation technology.

---

# 2. DESIGN PHILOSOPHY

System Evaluation follows the principles of:

- System-first evaluation
- Governance before release
- Layer-by-layer evaluation
- End-to-end validation
- Scientific reproducibility
- Continuous quality improvement
- Technology independence

---

# 3. ROLE

The System Evaluation Framework is responsible for:

- evaluating architectural components
- evaluating end-to-end workflows
- measuring system performance
- supporting release decisions
- preserving evaluation traceability

The framework is not responsible for:

- system implementation
- runtime monitoring
- deployment
- production incident handling

---

# 4. EVALUATION PHILOSOPHY

Evaluation shall assess the complete Safe Medical AI System.

Individual AI model performance alone shall not determine overall system quality.

The end-to-end patient education workflow constitutes the primary evaluation target.

---

# 5. MULTI-LAYER EVALUATION

Evaluation shall be performed independently for:

- Clinical Navigation
- Knowledge Governance
- Retrieval
- Evidence Package
- Response Generation
- Output Validation
- Delivery

An additional End-to-End Evaluation shall assess overall system behavior.

---

# 6. EVALUATION DIMENSIONS

Every evaluation shall consider standardized dimensions.

Minimum dimensions include:

- Clinical Accuracy
- Evidence Fidelity
- Safety
- Governance Compliance
- Explainability
- Robustness
- User Communication Quality

Additional dimensions may be introduced through governed amendments.

---

# 7. EVALUATION DATASETS

System Evaluation shall use governed evaluation datasets.

Evaluation datasets shall:

- be version controlled
- remain traceable
- represent clinical scenarios
- support reproducibility

Public benchmarks alone shall not constitute release evaluation.

---

# 8. LAYER-SPECIFIC METRICS

Each architectural layer shall maintain standardized metrics.

Illustrative metrics include:

Clinical Navigation

- Context Accuracy

Retrieval

- Precision
- Recall

Response Generation

- Evidence Fidelity
- Readability

Output Validation

- False Pass Rate
- False Reject Rate

Layer metrics shall remain independent from end-to-end metrics.

---

# 9. END-TO-END SCENARIO EVALUATION

Every release shall undergo scenario-based evaluation representing real patient journeys.

Scenario evaluation verifies interaction between architectural layers rather than isolated component performance.

---

# 10. HUMAN CLINICAL EVALUATION

Clinical experts shall participate in evaluating:

- Clinical Accuracy
- Patient Safety
- Communication Quality

Human evaluation complements automated evaluation and remains mandatory for governed releases.

---

# 11. REGRESSION EVALUATION

Every release shall undergo regression evaluation.

Regression evaluation verifies that system performance has not deteriorated relative to previously approved releases.

---

# 12. EVALUATION RECORD

Every evaluation shall generate a standardized Evaluation Record.

Minimum metadata include:

- Evaluation Identifier
- Evaluation Dataset Version
- Knowledge Base Version
- Prompt Specification Version
- Evaluation Framework Version
- Evaluation Timestamp

Additional metadata may be introduced through governed amendments.

---

# 13. RELEASE GATE

Production release requires successful completion of:

- Layer Evaluation
- End-to-End Evaluation
- Human Clinical Evaluation
- Regression Evaluation

Release approval shall not rely on any single evaluation criterion.

---

# 14. ARCHITECTURAL PRINCIPLES

The System Evaluation Framework follows:

- Governance-first evaluation
- Layer-based assessment
- End-to-end validation
- Explainability
- Traceability
- Scientific reproducibility
- Technology independence

---

# 15. RELATED DOCUMENTS

## Upstream

- OUTPUT_VALIDATION_FRAMEWORK.md
- DELIVERY_POLICY.md
- RESPONSE_GENERATION_ARCHITECTURE.md

## Downstream

- MONITORING_FRAMEWORK.md
- OBSERVABILITY_FRAMEWORK.md
- RELEASE_POLICY.md

---

# 16. AMENDMENT TRACEABILITY

## Version 1.0

Initial Release.

Locked Decisions Incorporated

LD-0209 — Evaluation Philosophy

LD-0210 — Multi-layer Evaluation

LD-0211 — Standard Evaluation Dimensions

LD-0212 — Governed Evaluation Dataset

LD-0213 — Layer-specific Metrics

LD-0214 — End-to-End Scenario Evaluation

LD-0215 — Human Clinical Evaluation

LD-0216 — Regression Evaluation

LD-0217 — Evaluation Record

LD-0218 — Release Gate